Inactive Instrument
Mymetics Corporation Stock Other OTC
Stocks
MYMX
US62856A1025
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 439K 386K 359K 330K 619K 42.08M 627K 4.27M 1.67M 20.78M 1.65M 1.61M 71.81M | P/E 2021 |
-1.86x | P/E 2022 | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 72.12M 63.4M 59.02M 54.2M 102M 6.92B 103M 702M 274M 3.42B 271M 265M 11.8B | EV / Sales 2021 |
177x | EV / Sales 2022 | 78x |
| Free-Float |
99.88% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2012-11-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.24% | +8.79% | - | - | 45 | |
| -1.82% | +4.80% | +56.71% | +68.36% | 57.28B | |
| -0.27% | +0.35% | +40.26% | +79.88% | 54.99B | |
| -2.05% | -2.14% | +0.75% | +413.38% | 23.18B | |
| +1.97% | -1.16% | -21.00% | -13.25% | 22.59B | |
| +1.19% | +1.05% | +22.73% | -7.73% | 20.46B | |
| +1.57% | +3.30% | +28.01% | -29.07% | 17.56B | |
| 0.00% | +1.88% | +38.63% | +545.91% | 15.67B | |
| +5.29% | +1.70% | +185.09% | +333.94% | 14.46B | |
| +0.79% | +0.50% | +22.39% | +184.74% | 13.92B | |
| Average | -0.60% | +1.51% | +41.51% | +175.13% | 26.68B | |
| Weighted average by Cap. | -0.13% | +1.53% | +39.80% | +136.92% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 430K 378K 352K 323K 607K 41.24M 615K 4.18M 1.63M 20.36M 1.61M 1.58M 70.38M | 1.03M 904K 841K 773K 1.45M 98.58M 1.47M 10M 3.91M 48.68M 3.86M 3.78M 168M |
| Net income | -4.73M -4.16M -3.87M -3.55M -6.67M -454M -6.76M -46.01M -17.97M -224M -17.76M -17.37M -774M | -4.8M -4.22M -3.93M -3.61M -6.78M -461M -6.87M -46.74M -18.25M -228M -18.04M -17.65M -786M |
| Net Debt | 67.1M 58.99M 54.91M 50.43M 94.69M 6.43B 95.94M 653M 255M 3.18B 252M 246M 10.98B | 71.68M 63.02M 58.66M 53.87M 101M 6.87B 102M 697M 272M 3.39B 269M 263M 11.73B |
Employees
-
